A method for characterising serum fibrinogen and fibrin degradation products.
暂无分享,去创建一个
[1] V. Kakkar,et al. A comparison of the sulphite and thrombin methods for measuring fibrinogen concentration of plasma from patients undergoing thrombolytic therapy. , 1976, Clinica chimica acta; international journal of clinical chemistry.
[2] P. Gaffney,et al. Distinction between fibrinogen and fibrin degradation products in plasma. , 1975, Clinica chimica acta; international journal of clinical chemistry.
[3] V. Kakkar,et al. TREATMENT OF DEEP-VEIN THROMBOSIS WITH INTERMITTENT STREPTOKINASE AND PLASMINOGEN INFUSION , 1975, The Lancet.
[4] P. Gaffney,et al. Soluble high-molecular-weight E fragments in the plasmin-induced degradation products of cross-linked human fibrin. , 1975, Clinical science and molecular medicine.
[5] T. Chard,et al. SERUM FIBRIN(OGEN) DEGRADATION PRODUCTS IN DIAGNOSIS OF DEEP-VEIN THROMBOSIS AND PULMONARY EMBOLISM AFTER HIP SURGERY , 1975, The Lancet.
[6] V. Kakkar,et al. Characterisation of a soluble D dimer-E complex in crosslinked fibrin digests. , 1975, Thrombosis research.
[7] T. Edgington,et al. A cleavage-associated neoantigenic marker for a gamma chain site in the NH2-terminal aspect of the fibrinogen molecule. , 1975, The Journal of biological chemistry.
[8] T. Edgington,et al. Conformational and structural modulation of the NH2-terminal regions of fibrinogen and fibrin associated with plasmin cleavage. , 1975, The Journal of biological chemistry.
[9] V. Marder,et al. Data for Defining Fibrinogen and Its Plasmic Degradation Products , 1975, Thrombosis and Haemostasis.
[10] T. Chard,et al. The Development of Radioimmunoassays for Fibrinogen Degradation Products: Fragments D and E , 1975, British journal of haematology.
[11] P. Cuatrecasas,et al. A simplified method for cyanogen bromide activation of agarose for affinity chromatography. , 1974, Analytical biochemistry.
[12] P. Gaffney,et al. Plasma Fibrinogen and its Fragments during Streptokinase Treatment , 1974, British journal of haematology.
[13] J. Gormsen,et al. Demonstration of different D-and E-antigenic intermediates during plasmin degradation of non-stabilized and stabilized fibrin clots. , 2009, Scandinavian journal of haematology.
[14] W. Hunter,et al. The use of antisera covalently coupled to agarose, cellulose and sephadex in radioimmunoassay systems for proteins and haptens. , 1973, Biochimica et biophysica acta.
[15] S. Pizzo,et al. Subunit structure of fragment D from fibrinogen and cross-linked fibrin. , 1973, Journal of Biological Chemistry.
[16] Garvey Mb,et al. The detection of fibrinogen-fibrin degradation products by means of a new antibody-coated latex particle. , 1972 .
[17] P. Gaffney,et al. A structural aspect of human fibrinogen suggested by its plasmin degradation , 1971, FEBS letters.
[18] R. Colman,et al. A comparative study of four methods for detecting fibrinogen degradation products in patients with various diseases. , 1970, The New England journal of medicine.
[19] K. Weber,et al. The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis. , 1969, The Journal of biological chemistry.
[20] V. Marder,et al. High molecular weight derivatives of human fibrinogen produced by plasmin. I. Physicochemical and immunological characterization. , 1969, The Journal of biological chemistry.
[21] H. G. Clarke,et al. Quantitative immunoelectrophoresis of human serum proteins. , 1968, Clinical science.
[22] C. Merskey,et al. Quantitative estimation of split products of fibrinogen in human serum, relation to diagnosis and treatment. , 1966, Blood.